Key Focus Area

Life Sciences

The Opportunity

Innovative treatment approaches that hold the promise to cure disease are oftentimes considered too risky and lack the necessary funding and resources. Yet the disease burden continues to grow, imposing tremendous costs in both lives and money. In particular, the prevalence of autoimmune diseases and allergies is increasing, and five-year cancer survival rates are virtually unchanged from 20 years ago despite an intensive four-decade effort. By 2030, cancer is expected to become the leading cause of death in the United States, surpassing heart disease.

Immunotherapies are one of the most promising developments to treat and cure these diseases, but there are currently significant financial and organizational barriers to their expansion. The Parker Foundation is committed to investing in new models and research in order to accelerate novel immunotherapies and treatment strategies to market that have the potential to improve health outcomes, reduce healthcare costs, and save millions of lives per year.


Who We Work With

  • Stand Up To Cancer
  • Standford Medicine
  • Cancer Research Institute
  • Penn Medicine
  • UCSF
  • Parker Institute for Cancer Immunotherapy

Other Beneficiaries

Cancer Research Institute

Cancer Research Institute

The Cancer Research Institute is the world's only nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers.

University of California San Francisco

University of California San Francisco

Research at the Immunology Program at University of California San Francisco will expand the understanding of autoimmune disease mechanisms in order to develop new therapies to improve treatments and reduce costs.

Weill Cornell Medical College

Weill Cornell Medical College

Weill Cornell Medical College provides care to patients with voice disorders and supports research geared at improving our understanding of voice disorders and developing new therapies.